The data shown below were collected from the profiles of 51 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
|
|---|---|
| Published in |
The Lancet Haematology, June 2024
|
| DOI | 10.1016/s2352-3026(24)00166-2 |
| Pubmed ID | |
| Authors |
Kim M Linton, Umberto Vitolo, Wojciech Jurczak, Pieternella J Lugtenburg, Emmanuel Gyan, Anna Sureda, Jacob Haaber Christensen, Brian Hess, Hervé Tilly, Raul Cordoba, David John Lewis, Craig Okada, Martin Hutchings, Michael Roost Clausen, Juan-Manuel Sancho, Tara Cochrane, Sirpa Leppä, Martine E D Chamuleau, Diana Gernhardt, Işıl Altıntaş, Yan Liu, Tahamtan Ahmadi, Minh H Dinh, Daniela Hoehn, Elena Favaro, Brian Elliott, Catherine Thieblemont, Julie M Vose |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 2% |
| United Kingdom | 1 | 2% |
| Brazil | 1 | 2% |
| United States | 1 | 2% |
| Unknown | 47 | 92% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 37 | 73% |
| Scientists | 9 | 18% |
| Science communicators (journalists, bloggers, editors) | 3 | 6% |
| Practitioners (doctors, other healthcare professionals) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 27 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 9 | 33% |
| Unspecified | 5 | 19% |
| Student > Ph. D. Student | 4 | 15% |
| Researcher | 2 | 7% |
| Professor > Associate Professor | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 5 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 11 | 41% |
| Medicine and Dentistry | 9 | 33% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Biochemistry, Genetics and Molecular Biology | 1 | 4% |
| Engineering | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 4 | 15% |
Attention Score in Context
This research output has an Altmetric Attention Score of 412. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2024.
All research outputs
#76,418
of 26,574,355 outputs
Outputs from The Lancet Haematology
#11
of 1,358 outputs
Outputs of similar age
#1,040
of 316,548 outputs
Outputs of similar age from The Lancet Haematology
#1
of 50 outputs
Altmetric has tracked 26,574,355 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,358 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,548 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.